Loading News...
Volver al Panel

Revvity, Inc. (RVTY)

Valores intradiarios en tiempo real

Resumen del Mercado

From:
To:
RVTY Intraday
No data available
SímboloRVTY
Fecha de SalidaFeb 21, 1973
CEODr. Prahlad R. Singh Ph.D.
Empleados a Tiempo Completo11k
SectorHealthcare
IndustriaDiagnostics & Research
PaísUnited States
BolsaNYSE
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, and training and services; and instruments, reagents, and assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. It also develops technologies that enable and support genomic workflows using protein coupled receptors and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Rendimiento
PeríodoRentabilidad %Cambio de Valor
1 Día
+0.87%
+1.37 US$
5 Días
+3.99%
+6.09 US$
1 Mes
+11.70%
+16.62 US$
6 Meses
+82.93%
+71.96 US$

Analizando el Mercado con IA

Evaluando los últimos 30 días de historial y métricas fundamentales de RVTY...

Estadísticas Clave
Cap. de Mercado
17.72B
Relación P/E
75.97
Rend. de Div.
0.18%
Máx. 52 Semanas
$166.25
Mín. 52 Semanas
$81.22

Consenso de Analistas

CONSENSOCompra
ALCISTA633.3%
NEUTRAL1161.1%
BAJISTA15.6%

Objetivos de Precios de Analistas a 52 Semanas

Objetivo Mín.
$110.00
Objetivo Máx.
$175.00
Actual$158.73
Objetivo Prom.$147.53

Recomendaciones de Analistas

Precio Objetivo:$147.53($110.00 - $175.00)
FirmaCalificaciónPrecio ObjetivoPotencial de AlzaFecha
TD CowenBuy$175.00+10.25%13/10/2026
BarclaysEqual-Weight$160.00+0.80%7/10/2026
William BlairOutperform$0.00-100.00%6/10/2026
KeybancOverweight$165.00+3.95%4/9/2026
RBC CapitalSector Perform$135.00-14.95%1/9/2026
Evercore ISI GroupOutperform$126.00-20.62%5/8/2026
Evercore ISI GroupOutperform$125.00-21.25%6/7/2026
BarclaysEqual-Weight$105.00-33.85%7/5/2026
JP MorganNeutral$90.00-43.30%6/5/2026
TD CowenBuy$120.00-24.40%6/5/2026
Pensamientos de la Comunidad

Comparta su análisis y sentimiento sobre RVTY

Únase a la comunidad para compartir su análisis